Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-08-21

Clinical Trial Update: Reflective Testing for Early Diagnosis of Pituitary Dysfunction [NA]

View source ↗

Summary

A clinical trial assessing reflective testing for early diagnosis of pituitary dysfunction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Nova Scotia Health Authority | Conditions: Pituitary Dysfunction | NA | Status: WITHDRAWN